The role of GPL-1 RAs in T2D

Should older patients with type 2 diabetes who already use insulin be considered for a GLP-1 RA? This video compares the two approaches, including hypoglycaemia risk, weight and injection frequency.

This activity comprises a short educational video, followed by a reflective activity. Participants must complete both components to qualify for 30 minutes of Reviewing Performance (RP) Hours.

Learning Outcomes

1. Outline the role and benefits of GLP-1 RAs in T2D management.
2. Critically reflect on your GLP-1 RA prescribing patterns to identify what currently influences your decisions
3. Reflect on how discussing the broader benefits of GLP-1 RAs could be integrated into your treatment positioning with T2D patients.

Provider

The Provider of this activity is Praxhub. Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com.